Anizatrectinib

DB21536ExperimentalSmall molecule

Anizatrectinib is a small molecule drug. The usage of the INN stem '-trectinib' in the name indicates that Anizatrectinib is a tropomyosin receptor kinase (TRK) inhibitor. Anizatrectinib has a monoisotopic...

Formula / weight: C₂₉H₃₂FN₇O₂ · 529.62 g/mol (avg)

Resolves to

Compound

UNII4D7KT2X8U2CAS1824664-89-2ChEMBLCHEMBL5095088ChEBI758672PubChem92135967

Structure

InChIKeyBGKSBHPSVMJTFL-IZZNHLLZSA-NSMILES[H][C@]1(CN(CCOC)C[C@H]1NC(=O)NC1=C(C)C(=NN1C1=CC=CC=C1)C1=CN=C(C)N=C1)C1=CC(F)=CC=C1

Targets

P04629NTRK1

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Anizatrectinib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account